Our Research

Discover our recent findings, catch up with news, and review in-depth resources.

Resolian Bioanalytics - Spectral Flow Cytometry

Blog

Spectral Flow Cytometry: From Trade-Offs to Total Clarity

Resolian combines the Cytek Aurora Full Spectrum Profiling platform with 25+ years of flow cytometry expertise to deliver complete immune clarity and confident, regulatory‑ready decisions for cell & gene therapy programs.
Read more
Overcoming Bioanalytical Challenges in siRNA Oligonucleotide Quantitation by LC-MS

Case Studies

Overcoming Bioanalytical Challenges in siRNA Oligonucleotide Quantitation by LC-MS

Turning Complexity into Clarity: Resolving siRNA Bioanalysis Challenges. How Resolian helps pharma and biotech partners overcome LC-MS hurdles for oligonucleotide quantitation.
Read more
Determination of Highly Polar Impurities in Drug Products

Case Studies

HPLC-UV Method Development for Highly Polar Impurities

Discover how Resolian developed and validated a GMP HPLC-UV method to achieve baseline resolution of highly polar impurities.
Read more
Evaluating Sustainable Solvents for Extractables & Leachables Testing

Case Studies | Videos

Sustainable Solvents for Extractables & Leachables

Can sustainable solvents match traditional E&L extraction performance? Resolian evaluates green alternatives that equal or exceed dichloromethane recovery.
Read more
Online SPE for Ultra-Trace Nitrosamine Quantification | Resolian

Case Studies | Videos

Solving Matrix Suppression in Ultra-Trace NDSRI Analysis

When excipients suppress your nitrosamine signal, tailored method development reveals the truth. Resolian’s systematic approach overcomes matrix interference.
Read more
Foreign Particulate Matter in Inhalation Products

Blog

Foreign Particulate Matter in Inhalation Products

Ensure inhalation product safety and compliance with Resolian’s advanced foreign particulate matter characterization and root cause analysis solutions.
Read more
Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Linkedin

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

 

Patrick Bennett

Chief Executive Officer

Linkedin

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.